Riskpilot← Back to searchSign inGet full accessRasch Medical AB
ABActiveOrg 5567805238Rental and operating of own or leased real estate · NACE 6820Est. 20090 employees
Revenue 2024
SEK 0
EBITDA margin
—
-22% vs 2023
Equity ratio
99.4%
Financial strength
Net profit 2024
SEK 562K
-93% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -88K | -22% |
| Net profit | SEK 562K | -93% |
| Total assets | SEK 42,6M | -9% |
| Equity | SEK 42,3M | +1% |
| Employees | 0 | — |
Legal name
Rasch Medical AB
Org number
5567805238
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
7 april 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva förvaltning av värdepapper och fastigheter samt konsultverksamhet inom hälso- och sjukvård och företags- ledning, samt därmed förenlig verksamhet.
Address
Email
dr_rasch@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 19 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −5 | −4 | −59 | −72 | −88 |
| Depreciation & amort. | −0 | −0 | −9 | −15 | −15 |
| EBIT | −5 | −4 | −68 | −87 | −102 |
| Net financials | −85 | 897 | 17 071 | 8 253 | 665 |
| Profit before tax | −90 | 893 | 17 003 | 8 166 | 562 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −90 | 893 | 17 003 | 8 166 | 562 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 042 | 22 397 | 39 162 | 46 890 | 42 562 |
| Equity | 17 538 | 18 431 | 35 434 | 41 966 | 42 323 |
| Long-term debt | 4 050 | 3 450 | 3 350 | 0 | — |
| Short-term debt | 1 454 | 516 | 378 | 4 924 | 238 |
| Total debt | 5 504 | 3 966 | 3 728 | 4 924 | 238 |
EBITDA margin
-8758900.0%
This company
15.8%
Market median
-55436176% vs market
20202024
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
56238900.0%
This company
8.1%
Market median
+694307307% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LM Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rasch Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Liz Maria Borg | Audit | 0 companies |
| Carl August Anton Rasch | Board of Directors | 0 companies |
| Inga Johanna Rasch | Deputy Board Member | 0 companies |